Team:Reading/Parts
From 2014.igem.org
(Difference between revisions)
(30 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
{{Head}} | {{Head}} | ||
- | + | <br><br><br><br><br><br><br><br><br><br> | |
- | + | ||
<html> | <html> | ||
<style type="text/css"> | <style type="text/css"> | ||
Line 9: | Line 8: | ||
<table width="70%" align="center"> | <table width="70%" align="center"> | ||
- | + | <!--Our parts--> | |
- | + | <h3 class="title"> Our parts</h3> | |
- | < | + | |
- | + | ||
- | + | ||
- | < | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | </ | + | |
<tr> <td colspan="3" height="10px"> </td></tr> | <tr> <td colspan="3" height="10px"> </td></tr> | ||
<tr><td bgColor="#e7e7e7" colspan="3" height="1px"> </tr> | <tr><td bgColor="#e7e7e7" colspan="3" height="1px"> </tr> | ||
<tr> <td colspan="3" height="5px"> </td></tr> | <tr> <td colspan="3" height="5px"> </td></tr> | ||
- | |||
<!--Parts Submitted to the Registry --> | <!--Parts Submitted to the Registry --> | ||
- | + | Genetic modification in | |
- | + | Synechocystis | |
- | + | is done by modifying the chromosome, | |
- | + | rather than inserting plasmids. Synechocystis is naturally transformable, and will | |
- | + | undergo homologous recombination between its chromosome and a plasmid | |
- | + | containing a homologous region. This means that plasmids for insertion or | |
- | + | deletion need to have regions of ~500 to ~1000bp either side of the inserted | |
- | + | sequence, making modifications time consuming or costly depending on your | |
- | + | method of plasmid construction. We will therefore submit all our BioBricks for | |
- | < | + | insertions and deletions to the registry. All of these will contain Kanamycin |
- | < | + | resistance for simple selection of transformants. |
- | < | + | <br /> |
- | + | <br /> | |
- | < | + | <center><img src="https://static.igem.org/mediawiki/2014/6/6c/Matt_bg11plate_1.jpg" width=600px></center> |
- | + | <br /> | |
- | </ | + | <center>Above: Wild-type <i>Synechocystis</i> transformed with a plasmid carrying kanamycin resistance.</center> |
- | + | <br /> | |
- | + | <br /> | |
- | + | The mechanism for each of the BioBricks is the same. They will undergo | |
- | < | + | recombination with the region that they share homology with. Knockouts will |
- | + | undergo recombination with the specified gene, replacing it with kanamycin resistance. Insertions will undergo recombination with a region of the | |
- | < | + | chromosome that is not important for the metabolic |
- | + | conditions we are using, and will insert the gene of interest along with a kanamycin resistance gene. | |
- | </ | + | <br /> |
- | </ | + | <br /> |
- | + | We are creating 4 BioBricks that will be submitted | |
- | + | to registry, consisting of 2 | |
- | < | + | deletions (<a href="http://parts.igem.org/Part:BBa_K1476003" title="Go to PsaD wiki page">PsaD</a> and <a href="http://parts.igem.org/Part:BBa_K1476000" title="Go to PilT1 wiki page">PilT1</a>) and 2 insertions (<a href="http://parts.igem.org/Part:BBa_K1476004" title="Go to PetF wiki page">PetF</a> and <a href="http://parts.igem.org/Part:BBa_K1476001" title="Go to PilA1 wiki Page">PilA1</a>). Background information on the aim of these parts can be |
- | + | found in our <a href="https://2014.igem.org/Team:Reading/Project" title="Go to project section">project section</a>. <br /> | |
- | < | + | <br /> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | </ | + | |
- | </ | + | |
- | + | ||
- | + | ||
<tr> <td colspan="3" height="15px"> </td></tr> | <tr> <td colspan="3" height="15px"> </td></tr> | ||
- | <tr><td | + | <tr><td><h3 class="title"> Reading iGEM 2014 parts</h3></td> |
- | + | <td></td> | |
- | + | ||
- | + | ||
- | + | ||
</table> | </table> |
Latest revision as of 00:31, 18 October 2014
University of Reading | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
Reading iGEM 2014 parts |
<groupparts>iGEM013 Reading</groupparts>
rusynbioigem@gmail.com |